Medical Corps and Nursing Corps, United States Air Force, USA.
Department of Epidemiology and Biostatistics, 8785University of California, San Francisco, San Francisco, CA, USA.
J Intensive Care Med. 2021 Feb;36(2):241-252. doi: 10.1177/0885066620980399.
Coronavirus disease 2019 (COVID-19) can lead to acute respiratory distress syndrome (ARDS) but it is unknown whether prone positioning improves outcomes in mechanically ventilated patients with moderate to severe ARDS due to COVID-19.
A cohort study at a New York City hospital at the peak of the early pandemic in the United States, under crisis conditions. The aim was to determine the benefit of prone positioning in mechanically ventilated patients with ARDS due to COVID-19. The primary outcome was in-hospital death. Secondary outcomes included changes in physiologic parameters. Fine-Gray competing risks models with stabilized inverse probability treatment weighting (sIPTW) were used to determine the effect of prone positioning on outcomes. In addition, linear mixed effects models (LMM) were used to assess changes in physiology with prone positioning.
Out of 335 participants who were intubated and mechanically ventilated, 62 underwent prone positioning, 199 met prone positioning criteria and served as controls and 74 were excluded. The intervention and control groups were similar at baseline. In multivariate-adjusted competing risks models with sIPTW, prone positioning was significantly associated with reduced mortality (SHR 0.61, 95% CI 0.46-0.80, < 0.005). Using LMM to evaluate the impact of positioning maneuvers on physiological parameters, the oxygenation-saturation index was significantly improved during days 1-3 ( < 0.01) whereas oxygenation-saturation index (OSI), oxygenation-index (OI) and arterial oxygen partial pressure to fractional inspired oxygen (PO: FiO) were significantly improved during days 4-7 (P < 0.05 for all).
Prone positioning in patients with moderate to severe ARDS due to COVID-19 is associated with reduced mortality and improved physiologic parameters. One in-hospital death could be averted for every 8 patients treated. Replicating results and scaling the intervention are important, but prone positioning may represent an additional therapeutic option in patients with ARDS due to COVID-19.
2019 年冠状病毒病(COVID-19)可导致急性呼吸窘迫综合征(ARDS),但尚不清楚对于 COVID-19 所致中重度 ARDS 患者,俯卧位通气是否能改善结局。
这是一项在美国 COVID-19 大流行早期、在纽约市一家医院进行的队列研究,处于危机状态。目的是确定 COVID-19 所致 ARDS 患者接受机械通气时俯卧位通气的益处。主要结局为院内死亡。次要结局包括生理参数的变化。采用 Fine-Gray 竞争风险模型结合稳定逆概率处理加权(sIPTW),确定俯卧位通气对结局的影响。此外,还采用线性混合效应模型(LMM)评估俯卧位通气对生理学的影响。
在 335 名接受插管和机械通气的患者中,62 名患者接受了俯卧位通气,199 名符合俯卧位通气标准且作为对照组,74 名患者被排除。干预组和对照组在基线时相似。在使用 sIPTW 的多变量调整竞争风险模型中,俯卧位通气与死亡率降低显著相关(SHR 0.61,95%CI 0.46-0.80,<0.005)。使用 LMM 评估定位操作对生理参数的影响,在第 1-3 天,氧合饱和度指数显著改善(<0.01),而在第 4-7 天,氧合饱和度指数(OSI)、氧合指数(OI)和动脉氧分压与吸入氧分数比值(PO:FiO)均显著改善(所有 P 值均<0.05)。
对于 COVID-19 所致中重度 ARDS 患者,俯卧位通气与死亡率降低和生理参数改善相关。每治疗 8 例患者即可避免 1 例院内死亡。复制结果和扩大干预范围很重要,但俯卧位通气可能是 COVID-19 所致 ARDS 患者的另一种治疗选择。